Today, we unveil the P4 randomized trial
The main question:
Can CT-guided PCI achieve similar outcomes compared to IVUS-guided PCI?
Join us in the Main Arena at #TCT2026@crfheart
Sunday morning #TCT2026@mattlkw elegantly summarises how and when to integrate imaging and physiology when assessing Left Main disease.
Safe to defer ≠ needs treatment
Always do (hyperaemic) pressure wire pullback from distal LAD
Imaging and physiology complementary
@JACCJournals Congratulations to the authors and thanks to #JACCINT@JACCJournals for the opportunity to provide editorial commentary on the PROVISION trial.
My musings on angiography-derived FFR available to read via the following link
https://t.co/nVUu8dxM9X
Thanks to #JACCINT@JACCJournals for the opportunity to provide editorial commentary on the PROVISION trial.
My musings on angiography-derived FFR available to read via the following link
https://t.co/nVUu8dxekp
Residual angina after PCI is common. The explanation depends on the interaction between microvascular dysfunction and the epicardial disease pattern
🎯 Focal CAD: successful PCI unmasks coexisting CMD.
〰️ Diffuse CAD: persistent epicardial resistance remains the dominant cause.
Impact of Coronary Microvascular Dysfunction on Patient-Reported Symptoms After PCI | https://t.co/EYxfNAQNi4
@crfheart@PCRonline@AbbottNews@bouissetfred #PCI #CoronaryPhysiology #CMD #PPG
First time at #EuroPCR@PCRonline a dedicated Physiology Course.
Physiology is becoming available in every case—#CCTCA, angio or invasive. Understanding the fundamentals is key to interpretation and decision-making.
FFR is not only an index; it is a concept.
Join us on Monday 18 in Paris. #Physiology #FFR
Don't miss it https://t.co/wNWDgkAXbW
FAME 2 long-term just published in @NatureMedicine
Stable CAD with FFR ≤0.80: FFR-guided PCI + MT vs MT alone ↓ death/MI/urgent revasc (33.6% vs 41.3%, win ratio 1.25, NNT~17)—mainly ↓ urgent revasc (10.1% vs 25.2%).
https://t.co/vrshqomEdD
At 10+ yrs Physiology still matters -> My digital avatar explains it all 🎥🤖 👇
@crfheart@TCTMD@PCRonline@AbbottNews@Heartflow@JACCJournals #FFR #PCI #StableCAD
Kicking off #TCT2025 on Saturday morning, we will present the 1 year clinical outcomes of patients treated with PCI in Focal vs Diffuse disease #PPG
Physiology will become more clinically relevant than ever before 💪🏻
Preview the #PPCI2025 programme ahead of tomorrow!
Highlights include a keynote lecture on PPCI after 55 by @ncurzen, case discussions from Leeds General Infirmary, hands-on sessions and debates on whether it’s time to rethink aspirin and beta-blockers, plus much more!
#PPCI
���2 weeks to go to INOCA 2025!
📍London SE1 7AR
@TheBHF @NIHRresearch
Incredible international faculty
How to sessions
Guideline updates
Informative talks
Debates
Live cases
Lived experience
Innovations in INOCA
‼️Register ASAP
https://t.co/UjWmimT9K9
Outstanding work! 👏
This is the first randomized study comparing resting and hyperemic pullbacks.
🔑 Key finding: Both resting (iFR) and hyperemic (FFR) pullbacks are equally influenced by lesion cross-talk.
✅ This settles a long-standing debate in the physiology field.
This first randomized comparison of FFR & iFR in serial #cvCAD shows that both FFR & iFR pullbacks overestimate hemodynamic benefits of #PCI. Post-PCI physiology should be routinely performed in diffuse & serial disease. https://t.co/oKY788cJrE
@divaka_perera@mattlkw#JACCINT
🚨FFR and iFR systematically overestimate the result of PCI in serial and diffuse coronary disease 🚨
#CoronaryPhysiology
🎲Randomised
👁️Blinded
🙋♀️Within patient comparison
🔗 Full link @JACCJournals
https://t.co/AFHt3W4VbE
📺Watch our summary below👇
Rapid exclusion of coronary microvascular dysfunction with novel contrast-derived indices of coronary microvascular function. A potential clinically useful, cost-saving method of testing @DamienCollison@_RobSykes@conor1366@DanielTYAng@ColinBerryMD https://t.co/TvRYO60OWH
1 week left to register for The Physiology Course (28–29 April)
50% OFF:
5 tickets for Physicians – Code: PHYSIO50OFFER
10 tickets for Fellows – Code: PHYSIO50FELLOWOFFER
Don't miss this opportunity & join the physiology of the future! https://t.co/JZ17kpsAfo
@CoreAalst
Thought-provoking new analysis from the FLAVOUR trial by Zhang et al this week.
Should PCI be guided by intracoronary physiology or by intacoronary imaging?
Do we need the best of both worlds?
Thanks to @JACCJournals for the invitation to comment.
https://t.co/WcbVXUBaBW